Stay updated on HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial

Sign up to get notified when there's something new on the HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added and the previous revision (v3.4.1) was removed from the page history. This is a minor update to the history display and does not alter the study record data.
    Difference
    0.0%
    Check dated 2026-02-13T12:37:13.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added to the history and Revision: v3.4.0 was removed.
    Difference
    0.0%
    Check dated 2026-02-05T14:28:11.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    On 2026-01-12, a new revision (v3.3.4) adds the Study Status and Contacts/Locations sections to the record and supersedes v3.3.3.
    Difference
    0.3%
    Check dated 2026-01-15T03:16:50.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    A new revision label (v3.3.3) was added and the HHS Vulnerability Disclosure link along with the v3.3.2 revision note were removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-24T15:27:32.000Z thumbnail image
  6. Check
    91 days ago
    Change Detected
    Summary
    New version 3.3.2 was added on 2025-11-20 with an updated Study Status; the prior revision v3.2.0 is removed.
    Difference
    0.2%
    Check dated 2025-11-25T21:22:36.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    Removed the government funding lapse disclaimer that used to appear on the page; its removal does not affect the study data, status details, or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T19:09:25.000Z thumbnail image

Stay in the know with updates to HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial page.